Labiana Health, S.A. (BME: LAB)
Health Care · Pharmaceuticals · ES
€5.35
-4.46% today · +30.2% 1Y
Labiana Health, S.A. (BME: LAB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $52.01M.
Over the last twelve months the share price has gained 30.2%, trading between 4.00 and 8.20.
Tweenvest scores Labiana Health, S.A. across four factors: quality 67/100, value 52/100, growth 62/100. Its strongest factor is quality.
LAB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $52.01M
- Revenue (TTM)
- $89.75M
- P/E
- 15.33
- EPS
- 0.37
- Dividend yield
- —
- Beta (5Y)
- 0.63
- 52-week high
- €8.20
- 52-week low
- €4.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.30M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Anya Biopharm Inc.TPEX: 7776 | $52.87M | NT$34.30 | +3.78% |
| Oncoinvent ASAOB: ONCIN | $52.71M | Nkr71.20 | -14.01% |
| Moberg Pharma AB (publ)OM: MOB | $52.47M | Skr11.48 | +3.05% |
| CKD Bio Corp.KOSE: A063160 | $52.10M | ₩12,790.00 | -0.23% |
| Enzychem Lifesciences CorporationKOSDAQ: A183490 | $51.50M | ₩— | — |
| SCYNEXIS, Inc.NasdaqCM: SCYX | $50.94M | $4.22 | -17.58% |
| May & Baker Nigeria plcNGSE: MAYBAKER | $50.92M | ₦39.20 | -5.08% |
| Infinium Pharmachem LimitedNSEI: INFINIUM | $50.86M | Rs314.25 | +19.90% |
Figures last refreshed Oct 4, 2026.